Microbiology and Auditing. Don Singer

Size: px
Start display at page:

Download "Microbiology and Auditing. Don Singer"

Transcription

1 Microbiology and Auditing Don Singer ASQ Northeast Pharmaceutical GMP/Quality Conference 2011

2 Through the eyes of a Microbiologist

3 Microbiology Audit = Inspection / Investigation

4 Systematic Auditing Planning Right People Tools Appropriate Objectives

5 Auditing approach Corporate design or policy Team Independent

6 Purpose Quality Systems Build robustness into your quality systems cgmps

7 Types of audits with Evaluation of Microbiological control Contract manufacture Contract microbiology laboratory Excipient manufacturer Active ingredient manufacturer Combination of any of the above Internal manufacture or laboratory

8 Quality Systems Inspection Quality system Production system Laboratory controls system Materials system Packaging and labeling system Facilities and equipment system

9 Microbiological Quality Risk Dosage form Management Laboratory tests Materials management

10 Risk by route of administration High Parenteral Ophthalmic Otic Wound topicals Nebulizer solution Intranasal solution Inhaled - DPI Inhaled - MDI Low Topical cream Topical ointment Oral solutions, suspensions Liquid-filled capsules Tablet, Capsule

11 Lab tests risk from impact of results High Sterility Test Bacterial endotoxin test Antimicrobial Preservatives Effectiveness Test Biological assays Microbial enumeration and Specified microorganisms tests Microbial identification Media growth promotion Low

12 Materials risk of contamination Manufacturing process Unprocessed High Classification Animal or plant origin (e.g. lactose) Highly processed Mineral origin (e.g. Talc) Some bioburden reduction processing Semi-synthetic origin (e.g. captisol, HPM) Mineral origin (e.g. dyes, aromatics) Low Synthetic origin (e.g. povidone)

13 Audit Expertise What is a QC Microbiologist? Knowledge Base : Science Origin and Growth Control

14 Microbiological Science

15 Origin and Growth Water (H 2 O) Nutrition (CHO, CHON, CHOOH, minerals, etc.) Presence or absence of components of air

16 Other Growth Factors ph temperature osmotic conditions light

17 Microbial Origin and Survival moderate to extreme environments solid to liquid dense to dilute atmosphere, humans and other living organisms (animals - vegetation), water, soil

18 Role of a QC Microbiologist Design for microbiological control Monitor to continuously evaluate

19 Control How to manipulate the environment Understand microbial growth limitations Determine how to reduce or eliminate microbial growth Understand dynamics of environment and microbiological growth / survival

20 Understand Thoroughly? Do you have the appropriate background and experience for microbiological investigation? If you do not, then partner with a Microbiologist

21 Tools to Assist cgmps, guidance docs, pharmacopeias Quality tools such as

22 Useful Quality Tools Assessment checklist or survey (developed by your Microbiologist colleague)

23

24 How does Risk fit Inspection decisions? High risk on-site inspection mandatory Moderate risk questionnaire assessment or on-site inspection Low risk questionnaire

25 Process flow chart Release of raw materials Fermentation Centrifugation Chromatography Bulk substance Filtration Final packaged product

26 Process analysis Excipients and Water Micronization Separation Drying Water Hydration Sterile filtration Filling

27 Details of Process with Controls HACCP plan Perform a virtual HACCP analysis using tour, procedures and assessment survey Amount of detail depends on level of risk

28 Audit Findings Template Same document format as Lead auditor Or Modified document for notes during audit For efficiency and clarity. Agreed on format with Lead auditor

29 Objectives I perform an audit with these intended goals: 1. Determine quality systems in place for microbiological control 2. Determine level of knowledge and capabilities of audited site 3. Determine if continuous improvement is part of culture

30 Objectives (cont.) 4. Determine if culture matches ours 5. Share knowledge and perspective with client where adds value 6. Develop a relationship based on respect, shared learning, communications

31 Right People Participants To ensure that adequate and timely information is generated during an audit Questions should be directed to the Microbiologist who has accountability and responsibility, and possibly to their staff Additionally, communicate with operators, or validation scientists, if appropriate (e.g. for sterile operations)

32 Success or Failure The results from an audit depend on the accuracy of information A non-microbiologist should have effective access to someone who is educated in pharmaceutical microbiology

33 Virtual Audit with a Microbiology Auditor

34 Criteria to Consider for Manufacturing Audits Excipient control C of A, specs, QC testing, material storage, weighing Process flow containment, gowning Process equipment validation, cleaning, sterilization, microbial monitoring Process areas cleaning, sanitization, access control, gowning, gloves, microbial monitoring, classification qualification Source of water, water system control and monitoring

35 Criteria to Consider for Manufacturing Audits Formulation excipient and component handling, bulk material handling, in-process sampling, hold time qualifications Dosage dependent manufacture controls (e.g. mixing, drying, milling, compaction) Finish/fill operations sampling, cleaning, operator technique/intervention, controls (e.g. filtration, sterilization, closure control), process qualification Finished product QC testing, stability testing

36 Criteria to Consider for Laboratory Audits Organization and reporting structure Laboratory layout Sample tracking, storage Media control, made or purchased Supplies, reagents control Instrument control calib., PM Lab and instrument cleaning, disinfection

37 Criteria to Consider for Laboratory Audits Lab monitoring SOPs and their control Microbial identification process Exceeded limit or atypical result procedure Quality improvement program, measures Proficiency testing Test methodology Method suitability procedures

38 Criteria to Consider for API or Excipient Manufacture Audit Process flow and contributing factors (e.g. intended use of compound, parenteral vs. non-sterile) Monitoring of process Origin and control of raw ingredients Water system control and monitoring Microbial monitoring of product

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services

More information

World Health Organization Prequalification of Medicines

World Health Organization Prequalification of Medicines Dr André van Zyl World Health Organization Prequalification of Medicines Manufacturers meeting April 2011 Head of Inspections vanzyla@who.int 1 WHO GMP In this presentation: Background and Introduction

More information

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research Available on line www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(2):892-898 World Health Organization s Guidelines for

More information

Understanding USP 797

Understanding USP 797 DDK Scientific, Corp. Raul Duarte June 2008 Copyright DDK Scientific, Corp. 2008, 2009 DDK Scientific, Corp. Proprietary The purpose of USP 797 is to prevent harm and fatality to patients that could result

More information

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing

More information

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION 1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information

More information

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER DISCUSSION IN THE HMPWG 2003-2005 RELEASE FOR CONSULTATION December 2005 DEADLINE

More information

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

FDA and the Compounding Pharmacy

FDA and the Compounding Pharmacy FDA and the Compounding Pharmacy Scott Sutton, Ph.D. scott.sutton@microbiol.org 41 Overview of Presentation The Recent Events GCP and GMP Basics the 483 Review H.R. 3204 Outsourcing Facility Preparation

More information

The Microbial Bioburden of USP 797 Compliance. Simplifying Environmental Quality and Control Practices for Pharmaceutical Compounding

The Microbial Bioburden of USP 797 Compliance. Simplifying Environmental Quality and Control Practices for Pharmaceutical Compounding The Microbial Bioburden of USP 797 Compliance Simplifying Environmental Quality and Control Practices for Pharmaceutical Compounding PathCon Laboratories Fall 2009 Table of Contents Introduction a primer

More information

Hazard Analysis and Critical Control Points (HACCP) 1 Overview

Hazard Analysis and Critical Control Points (HACCP) 1 Overview Manufacturing Technology Committee Risk Management Working Group Risk Management Training Guides Hazard Analysis and Critical Control Points (HACCP) 1 Overview Hazard Analysis and Critical Control Point

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Changes to an Approved NDA or ANDA U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) April 2004 CMC Revision

More information

CONCEPTS OF FOOD SAFETY QUALITY MANAGEMENT SYSTEMS. Mrs. Malini Rajendran

CONCEPTS OF FOOD SAFETY QUALITY MANAGEMENT SYSTEMS. Mrs. Malini Rajendran CONCEPTS OF FOOD SAFETY AND QUALITY MANAGEMENT SYSTEMS Mrs. Malini Rajendran Brief background 1963 - The Codex Alimentarius Commission was created by FAO and WHO to develop food standards, guidelines and

More information

Guidance for Industry: Starting Material Supplier Management

Guidance for Industry: Starting Material Supplier Management Guidance for Industry: Starting Material Supplier Management Version 1.0 Drug Office Department of Health. Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. Selecting and

More information

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Guidance for Industry Current Good Manufacturing Practice Interim Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act DRAFT GUIDANCE This guidance document is

More information

Leila Kakko Tampere University of Applied science TRADITIONAL FOOD IN COMBATING FOODBORNE PATHOGENS 2011

Leila Kakko Tampere University of Applied science TRADITIONAL FOOD IN COMBATING FOODBORNE PATHOGENS 2011 Leila Kakko Tampere University of Applied science TRADITIONAL FOOD IN COMBATING FOODBORNE PATHOGENS 2011 World Food Programme Food quality control is necessary to ensure that food aid supplies are safe,

More information

On-Site GMP Training GMP COMPLIANCE TECHNICAL

On-Site GMP Training GMP COMPLIANCE TECHNICAL PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program

More information

Catalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health

Catalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health Global Education Catalog 2013 2014 and Training Global Expertise Trusted Standards Improved Health USP s mission is to improve global health through public standards and related programs that help ensure

More information

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Risk-Based Environmental Monitoring Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI Presenter Marsha Stabler Hardiman Over 20 years experience in the

More information

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human

More information

ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products

ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit CPMP/ICH/380/95 ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products

More information

HAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR

HAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR HAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR I. INTRODUCTION A. CARAMEL COLOR 1. Caramel Color (Caramel) is defined in Title 21 of the U.S. Code of

More information

MeriCal Quality Profile

MeriCal Quality Profile January 5, 2015 Dear Valued Customer, Since the implementation of new federal regulations, MeriCal Inc. has received a large volume of questionnaires and surveys regarding our services and procedures.

More information

Guidance for Industry

Guidance for Industry Guidance for Industry INDs for Phase 2 and Phase 3 Studies Chemistry, Manufacturing, and Controls Information U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

A Process Verification Model Quality Assurance in a Compounding Pharmacy

A Process Verification Model Quality Assurance in a Compounding Pharmacy ba ic f c mp unding quali y-c n l analy ical me d p e c ip i n A Process Verification Model calcula for i n Quality Assurance in a ma ke ing Compounding Pharmacy Abstract There are virtually thousands

More information

Guidance for Industry ANDAs: Stability Testing of Drug Substances and Products

Guidance for Industry ANDAs: Stability Testing of Drug Substances and Products Guidance for Industry ANDAs: Stability Testing of Drug Substances and Products Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

cgmp Challenges for Cord Blood Banks

cgmp Challenges for Cord Blood Banks cgmp Challenges for Cord Blood Banks Donna M. Regan, MT(ASCP)SBB St. Louis Cord Blood Bank @ SSM Cardinal Glennon Children s s Medical Center Cord Blood Bank processing facility challenges What does cgmp

More information

Annex 7 Guidelines on pre-approval inspections

Annex 7 Guidelines on pre-approval inspections World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the

More information

Highly Potent APIs The right platform, people and procedures for successful development and manufacturing

Highly Potent APIs The right platform, people and procedures for successful development and manufacturing Pharma&Biotech Highly Potent APIs The right platform, people and procedures for successful development and manufacturing Custom Manufacturing and Development Services for Highly Potent APIs Pharma&Biotech

More information

ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING

ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING For More Information on Submission of an ANDA in Electronic Common Technical Document (ectd) Format

More information

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011

More information

Annex 6. Guidance on variations to a prequalified product dossier. Preface

Annex 6. Guidance on variations to a prequalified product dossier. Preface Annex 6 Guidance on variations to a prequalified product dossier Preface This guidance document was technically and structurally inspired by the Guideline on dossier requirements for type IA and IB notifi

More information

Manufacturing process of biologics

Manufacturing process of biologics Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:

More information

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants September 1999 Table of contents 1. Foreword...... 2 2. Objective...... 3 3. Scope........ 4 4. Potential residues... 5 5. Current

More information

2014 Annual Report on Inspections of Establishments

2014 Annual Report on Inspections of Establishments 2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered

More information

Department of Food Science Food Processing FSE98(10-99)

Department of Food Science Food Processing FSE98(10-99) Department of Food Science Food Processing FSE98(10-99) Choosing and Using a Copacker John E. Rushing, Ph.D. What is a copacker? Copackers manufacture and package foods for other companies to sell. These

More information

Supply Chain Challenges and Risk Management

Supply Chain Challenges and Risk Management Supply Chain Challenges and Risk Management Presented by Steve Williams Director SeerPharma P/L 21 st April 2009 PDA April 09 SW 1 Supply Chain - Some Useful Guidance cgmp Annex 8 cgmp Chapter 7 ICH Q7

More information

GMP Pharma BV. Netherlands

GMP Pharma BV. Netherlands GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization

More information

Cleanroom. For. Sterile Manufacturing Facilities

Cleanroom. For. Sterile Manufacturing Facilities Cleanroom For Sterile Manufacturing Facilities Praphon Angtrakool Food and Drug Administration 1 WHO TRS No. 823 Annex 1, 1992 (1) General 17.1 The production of sterile preparations should be carried

More information

Xiaoming Wang, MD. MS. Manager QC Microbiology ImClone Systems A wholly-owned subsidiary of Eli-Lilly and Company

Xiaoming Wang, MD. MS. Manager QC Microbiology ImClone Systems A wholly-owned subsidiary of Eli-Lilly and Company Xiaoming Wang, MD. MS Manager QC Microbiology ImClone Systems A wholly-owned subsidiary of Eli-Lilly and Company USP Microbiological Best Laboratory Practices USP 32 page 616 Introduction: good laboratory

More information

Pharmacy Technician Training Program. Minimum Competencies

Pharmacy Technician Training Program. Minimum Competencies 1. Pharmacy Practice Pharmacy Technician Training Program Minimum Competencies 1.1 The candidate shall be familiar with the mission of pharmacy and the various permitted pharmacy practice sites. The candidate

More information

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high

More information

Questionnaire Layout:

Questionnaire Layout: Raw Material Supplier Questionnaire Introduction: This questionnaire has been developed by the EHPM quality working group. It combines work carried out by EHPM various national associations in developing

More information

Guideline on Process Validation

Guideline on Process Validation 1 2 3 4 29 March 2012 EMA/CHMP/CVMP/QWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) 5 6 Draft Draft Agreed by CHMP /

More information

Guidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers

Guidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers Guidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center

More information

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS 1 WHAT IS A SITE MASTER FILE? A Site Master File (SMF) is a document prepared by the manufacturer containing specific

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS European Medicines Agency Inspections London, 21 June 2006 Doc Ref.: EMEA/CHMP/QWP/49313/2005 Corr COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION

More information

FILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS

FILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS FILTRATION SOLUTIONS Pharmaceutical Manufacturing filtration specialists Delivering quality filtration products As one of Europe s leading manufacturers of process filters, Amazon Filters is able to offer

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE THE COMMON TECHNICAL DOCUMENT FOR THE REGISTRATION

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

Annex 9 Guide to good storage practices for pharmaceuticals 1

Annex 9 Guide to good storage practices for pharmaceuticals 1 World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 9 Guide to good storage practices for pharmaceuticals 1 1. Introduction 125 2. Glossary 126 3. Personnel 128 4. Premises and facilities

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products For questions on the content of the guidance,

More information

Global Lab Capabilities Pharma Biotech

Global Lab Capabilities Pharma Biotech Global Lab Capabilities Pharma Biotech NSF Health Sciences global network of laboratories delivers expert solutions to pharmaceutical, biotechnology and medical device companies in the areas of analytical

More information

Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA

Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels Master of Drug Regulatory Affairs

More information

Overview of Pre-Approval Inspections

Overview of Pre-Approval Inspections Overview of Pre-Approval Inspections Presented by: Kelli F. Dobilas NWJ-DO Pre-Approval Manager Pre-Approval Drug Inspections What are Pre-Approval Inspections? One of the last reviews of the drug approval

More information

Annex 7 WHO guidelines on transfer of technology in pharmaceutical manufacturing

Annex 7 WHO guidelines on transfer of technology in pharmaceutical manufacturing World Health Organization WHO Technical Report Series, No. 961, 2011 Annex 7 WHO guidelines on transfer of technology in pharmaceutical manufacturing 1. Introduction 2. Scope 3. Glossary 4. Organization

More information

tdodds@jeffyuen.com 714 282-1014 Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA 92863 Terri Dodds CAPT. (RET) TERRI L.

tdodds@jeffyuen.com 714 282-1014 Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA 92863 Terri Dodds CAPT. (RET) TERRI L. SKILLS/SPECIAL QUALIFICATIONS: Regulatory Expertise: Technical Expertise: CAPT. (RET) TERRI L. DODDS - BSN, RN Former Public Health Service (PHS) Officer with 16 years of FDA experience in Pharmaceuticals,

More information

LIBRARY GUIDE. Online Courses. March 2012

LIBRARY GUIDE. Online Courses. March 2012 LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................

More information

RESOLUTION-RDC Nr- 48, OF OCTOBER 6, 2009

RESOLUTION-RDC Nr- 48, OF OCTOBER 6, 2009 RESOLUTION-RDC Nr- 48, OF OCTOBER 6, 2009 This resolution provides for the alteration, inclusion, suspension, reactivation and cancellation after registration of medications and sets forth other provisions.

More information

Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh

Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh Production Records & Documentation Diane Kadidlo MT(ASCP) SBB University of Minnesota Joanna Stanson, M.S. University of Pittsburgh Production Records This Session: Production Records Basic Elements Regulatory

More information

Cleaning. By the end of this chapter, you will be able to: Introduction. Definitions. Chapter 9

Cleaning. By the end of this chapter, you will be able to: Introduction. Definitions. Chapter 9 Chapter 9 By the end of this chapter, you will be able to: l Define the terms cleaning, decontamination, disinfection l List the factors that affect disinfection l Describe the aims of a cleaning schedule

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL

More information

GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS

GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE DRAFT CONSENSUS GUIDELINE GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL

More information

*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV

*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV WHO/VSQ/97.03 Original: English Distribution: General *XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV 3UHSDUHGE\*LOOLDQ&KDORQHU/DUVVRQ3K'*&/%LRFRQVXOW 2WWDZD&DQDGD /LQNWR&RQWHQWVSDJH GLOBAL PROGRAMME

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL Site Master File GUIDELINES FOR PREPARATION OF SITE MASTER FILE This document has been prepared as a guide to assist applicants to comply with the requirements for Site Master

More information

Microbiological Best Laboratory Practices, USP <1117> Value and Recent Changes to a Guidance of Quality Laboratory Practices

Microbiological Best Laboratory Practices, USP <1117> Value and Recent Changes to a Guidance of Quality Laboratory Practices «MICROBIOLOGY» Microbiological Best Laboratory Practices, USP Value and Recent Changes to a Guidance of Quality Laboratory Practices Scott Sutton 1, Ph.D. and Donald Singer 2 1 President, Microbiology

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products- authorisations, European Medicines Agency Brussels, EudraLex The Rules Governing Medicinal

More information

GUIDELINES FOR MANAGEMENT AND HANDLING OF SPENT MYCELIUM FROM BULK DRUG INDUSTRY

GUIDELINES FOR MANAGEMENT AND HANDLING OF SPENT MYCELIUM FROM BULK DRUG INDUSTRY GUIDELINES FOR MANAGEMENT AND HANDLING OF SPENT MYCELIUM FROM BULK DRUG INDUSTRY MAHARASHTRA POLLUTION CONTROL BOARD Kalpataru Point, Sion (E), Mumbai 400 022. E-mail : mpcb@vsnl.net Web site : http://mpcb.mah.nic.in

More information

Pharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success

Pharmaceuticals Production Services Boehringer Ingelheim. Our expertise in world-class contract manufacturing for your success Pharmaceuticals Production Services Boehringer Ingelheim Our expertise in world-class contract manufacturing for your success Successful partnership Dr Wolfram Carius Head of Corporate Division Pharmaceuticals

More information

SERVICES FOR. Devices and Combination Products

SERVICES FOR. Devices and Combination Products SERVICES FOR Devices and Combination Products How to Contact Us U.S. FACILITIES / CLIENT SERVICES St. Paul 2540 Executive Drive St. Paul, MN 55120 FAX 651.675.2005 Atlanta 1265 Kennestone Circle Marietta,

More information

EC 691 January 1996 HACCP AND MICROBREWERIES PRACTICAL GUIDELINES OF FOOD SAFETY FOR MICROBREWERIES, BREWPUBS AND THE BEER INDUSTRY

EC 691 January 1996 HACCP AND MICROBREWERIES PRACTICAL GUIDELINES OF FOOD SAFETY FOR MICROBREWERIES, BREWPUBS AND THE BEER INDUSTRY EC 691 January 1996 HACCP AND MICROBREWERIES PRACTICAL GUIDELINES OF FOOD SAFETY FOR MICROBREWERIES, BREWPUBS AND THE BEER INDUSTRY TABLE OF CONTENTS I. Purpose of this publication... 3 II. Introduction...

More information

Open Microphone Meeting:

Open Microphone Meeting: Open Microphone Meeting: USP General Chapter Pharmaceutical Compounding Sterile Preparations October 21, 2015 2:00 p.m. to 4:00 p.m. EDT Agenda Welcome Overview of USP s Revision Process Overview

More information

Pharmaceutical Quality Systems: US Perspective

Pharmaceutical Quality Systems: US Perspective Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical

More information

Oxivir Tb and Accelerated Hydrogen Peroxide (AHP) Frequently Asked Questions

Oxivir Tb and Accelerated Hydrogen Peroxide (AHP) Frequently Asked Questions Oxivir Tb and Accelerated Hydrogen Peroxide (AHP) Frequently Asked Questions What is Accelerated Hydrogen Peroxide (AHP)? AHP is a patented synergistic blend of commonly used, safe ingredients that when

More information

USP s mission is to improve global health through public. standards and related programs that help ensure the quality,

USP s mission is to improve global health through public. standards and related programs that help ensure the quality, 2015 Catalog USP s mission is to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. 2 Courses listed as of January

More information

PEOPLE > SCIENCE > SOLUTIONS

PEOPLE > SCIENCE > SOLUTIONS PEOPLE > SCIENCE > SOLUTIONS Our difference Our foundation Our focus ANALYTICAL CHEMISTRY & MATERIALS CHARACTERIZATION EFFICACY (Functional testing) BIOCOMPATIBILITY (in vivo & in vitro toxicology) CLINICAL

More information

Position Classification Standard for Pharmacy Technician Series, GS-0661

Position Classification Standard for Pharmacy Technician Series, GS-0661 Position Classification Standard for Pharmacy Technician Series, GS-0661 Table of Contents SERIES DEFINITION... 2 SERIES COVERAGE... 2 EXCLUSIONS... 4 TITLES... 4 NOTES TO USERS OF THIS STANDARD... 5 CLASSIFICATION

More information

Standards for the initial education and training of pharmacy technicians

Standards for the initial education and training of pharmacy technicians Standards for the initial education and training of pharmacy technicians September 2010 2 Standards for the initial education and training of pharmacy technicians The General Pharmaceutical Council is

More information

Cord Blood Licensure. Session 2C: Advanced Cell Therapies April 11, 2013

Cord Blood Licensure. Session 2C: Advanced Cell Therapies April 11, 2013 Cord Blood Licensure Session 2C: Advanced Cell Therapies April 11, 2013 Objectives Describe rationale for cord blood licensure Cite licensure regulations Illustrate a case study of one program s pathway

More information

Quality assurance of pharmaceuticals

Quality assurance of pharmaceuticals QAPPR 12/16/06 12:10 PM Page i Quality assurance of pharmaceuticals A compendium of guidelines and related materials Volume 2, 2nd updated edition Good manufacturing practices and inspection QAPPR 12/16/06

More information

The Formalized Risk Assessment for Excipients A Practical Approach. Frithjof Holtz, IPEC Europe Vice-Chair, Merck

The Formalized Risk Assessment for Excipients A Practical Approach. Frithjof Holtz, IPEC Europe Vice-Chair, Merck The Formalized Risk Assessment for Excipients A Practical Approach Frithjof Holtz, IPEC Europe Vice-Chair, Merck Presentation Overview Regulatory Background EU FMD and Formalized Risk Assessment Proposal

More information

Scanning Electron Microscopy Services for Pharmaceutical Manufacturers

Scanning Electron Microscopy Services for Pharmaceutical Manufacturers Scanning Electron Microscopy Services for Pharmaceutical Manufacturers Author: Gary Brake, Marketing Manager Date: August 1, 2013 Analytical Testing Laboratory www.atl.semtechsolutions.com Scanning Electron

More information

Biotechpharma company profile

Biotechpharma company profile Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing

More information

Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals

Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals 1. Introduction Traditionally,

More information

Design, Operation and Management of GTP/GMP Cell Engineering Facilities

Design, Operation and Management of GTP/GMP Cell Engineering Facilities Design, Operation and Management of GTP/GMP Cell Engineering Facilities Scott R. Burger, MD Advanced Cell & Gene Therapy BFDA 2007 International Symposium on Regulation of Human Cell and Tissue- Based

More information

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)

More information

The Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009

The Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009 The Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009 Nena Dockery Introduction and History of Use Commercial production of enzymes for use as digestive aids has an extensive history

More information

Workshop A Design Space (DS)

Workshop A Design Space (DS) Implementation of ICH Q8, Q9, Q10 Workshop A Design Space (DS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Disclaimer The information

More information

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

PHARMACEUTICAL TRAINING GUIDELINE

PHARMACEUTICAL TRAINING GUIDELINE PHARMACEUTICAL TRAINING GUIDELINE 5850 Boymel Dr. Suite 1 Fairfield, OH 45014 Tel.: 513.860.3512 Fax: 513.860.3406 www.compliance-insight.com Reorder Item No. 20.020.2 PHARMACEUTICAL TRAINING GUIDELINE

More information

Pharmacy Investigational Drug Services for Clinical Research

Pharmacy Investigational Drug Services for Clinical Research Pharmacy Investigational Drug Services for Clinical Research Jennifer Colon, PharmD, MS, MBA Pharmacy Clinical Specialist-Investigational Drug Services Temple University Hospital Adjunct Clinical Professor-Temple

More information

[See Rules 74,74-A, 74-B, 78 and 78-A] A. SUBSTANCES OTHER THAN PARENTERAL IN PREPARATIONS IN GENERAL

[See Rules 74,74-A, 74-B, 78 and 78-A] A. SUBSTANCES OTHER THAN PARENTERAL IN PREPARATIONS IN GENERAL 29 [SCHEDULE U [See Rules 74,74-A, 74-B, 78 and 78-A] I. Particulars to the shown in /manufacturing Records A. SUBSTANCES OTHER THAN PARENTERAL IN PREPARATIONS IN GENERAL 1. Serial number. 2. Name of the

More information

Extemporaneously Prepared Early Phase Clinical Trial Materials

Extemporaneously Prepared Early Phase Clinical Trial Materials Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities)

ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities) November 2012 EMA/CHMP/ICH/425213/2011 ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/ biological entities) Step 5 Transmission to CHMP May

More information

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories

More information

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1 Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and

More information

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT Guideline Title Specifications and Control Tests on the Finished Product Legislative basis Directive 75/318/EEC as amended Date of first adoption

More information